# United Therapeutics Corporation (UTHR) FY2026 YTD Q2 Statement of Cash Flows

- Company: United Therapeutics Corporation (UTHR)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001082554-26-000027
- Page: https://plicit.ai/financials/uthr/fy2026-ytd-q2-cash-flow
- Chart image: https://plicit.ai/charts/uthr-fy2026-ytd-q2-cash-flow-sankey.png

## Chart details

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Dec 31, 2025**: 1,557,100,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: 776,900,000 US dollars. Net cash provided.
- **Net income**: 607,900,000 US dollars
- **Depreciation and amortization**: 46,800,000 US dollars
- **Share-based compensation expense**: 77,300,000 US dollars
- **Other**: 56,800,000 US dollars
- **Accounts receivable**: 39,900,000 US dollars
- **Inventories**: negative 57,800,000 US dollars
- **Accounts payable and accrued expenses**: negative 16,700,000 US dollars
- **Other assets and liabilities**: negative 77,100,000 US dollars
- **Net unrealized losses on equity securities**: 48,200,000 US dollars
- **Deferred income taxes**: 51,600,000 US dollars
- **Impairment of property, plant, and equipment**: 0 US dollars
- **Investing activities**: 831,200,000 US dollars. Net cash provided.
- **Purchases of property, plant, and equipment**: negative 208,800,000 US dollars
- **Deposits**: negative 6,400,000 US dollars
- **Purchases of available-for-sale debt securities**: negative 770,800,000 US dollars
- **Maturities of available-for-sale debt securities**: 534,300,000 US dollars
- **Sales of available-for-sale debt securities**: 1,307,900,000 US dollars
- **Purchase of investment in privately held company**: negative 25,000,000 US dollars
- **Financing activities**: negative 1,362,000,000 US dollars. Net cash used.
- **Payments to repurchase common stock**: negative 1,500,000,000 US dollars
- **Proceeds from line of credit**: 0 US dollars
- **Repayment of line of credit**: 0 US dollars
- **Excise tax paid on net share repurchase**: 0 US dollars
- **Payments of debt issuance costs**: negative 3,400,000 US dollars
- **Proceeds from the exercise of stock options**: 194,600,000 US dollars
- **Proceeds from the issuance of stock under ESPP**: 5,600,000 US dollars
- **RSUs withheld for taxes**: negative 58,800,000 US dollars
- **Operating adjustment reconciliation**: 320,600,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 1,562,200,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 1,842,200,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 0 US dollars
- **Ending cash on Jun 30, 2026**: 1,803,200,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 3,165,200,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 246,100,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: 1.28×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: 776,900,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 208,800,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: 568,100,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $169.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 776,900,000 US dollars minus 208,800,000 US dollars equals 568,100,000 US dollars.